P01-64 Approaches to mitigate known safety liabilities of immunomodulatory (IMiDs) drugs used in heterobifunctional degraders

Autor: Rodrigo, M., Komen, J., Regan, S., Hamza, G., Andres, A., Leonard, E., Michaelides, I., Moreau, K.
Zdroj: In Toxicology Letters September 2024 399 Supplement 2:S96-S97
Databáze: ScienceDirect